Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Jounce Therapeutics Inc.

    NASDAQ: JNCE · Real-Time Price · USD
    1.88
    0.00 (0.00%)
    At close: May 03, 2023, 10:00 PM

    Jounce Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 82M n/a n/a n/a 26.91 n/a 25.37M 1.54M
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 82M n/a n/a n/a 26.91 n/a 25.37M 1.54M
    Operating Income
    		 50.34M -31.41M -33.71M -37.46M 30K -30.14M -4.05M -26.58M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 51.08M -30.99M -33.5M -37.37M 30K -30.09M -4.01M -26.53M
    Net Income
    		 50.96M -31M -33.51M -37.37M 30K -30.09M -4.01M -26.54M
    Selling & General & Admin
    		 8.46M 7.65M 7.51M 7.35M -6.83K 6.85M 7.32M 7.62M
    Research & Development
    		 23.2M 23.75M 26.2M 30.11M -23.2K 23.29M 22.1M 20.51M
    Other Expenses
    		 n/a n/a 213K 96K n/a n/a n/a n/a
    Operating Expenses
    		 31.66M 31.41M 33.71M 37.46M -30.02K 30.14M 29.42M 28.12M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 31.66M 31.41M 33.71M 37.46M -30.02K 30.14M 29.42M 28.12M
    Income Tax Expense
    		 117K 5K 12K 1K -5.99 6K 2K 1K
    Shares Outstanding (Basic)
    		 51.68M 51.69M 51.68M 51.64M 51.25M 51.23M 51.21M 45.96M
    Shares Outstanding (Diluted)
    		 51.68M 51.69M 51.68M 51.64M 51.25M 51.23M 51.21M 45.96M
    EPS (Basic)
    		 0.99 -0.6 -0.65 -0.72 0.00 -0.59 -0.08 -0.58
    EPS (Diluted)
    		 0.99 -0.6 -0.65 -0.72 0.00 -0.59 -0.08 -0.58
    EBITDA
    		 50.78M -30.91M -33.15M -36.87M 673K -29.4M -3.29M -25.75M
    EBIT
    		 50.34M -31.41M -33.71M -37.46M 30K -30.14M -4.05M -26.58M
    Depreciation & Amortization
    		 442K 495K 560K 590K 643K 683K 716K 785K

    Add to Watchlist